Alexandros Stamatopoulos

Dr. Alexandros Stamatopoulos

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Bone Oncology
Verified
Journal Article
Open access
EPEvgenia Papakonstantinou
Evgenia Papakonstantinou
ASAlexandros Stamatopoulos
Alexandros Stamatopoulos
DADimitrios I Athanasiadis
Dimitrios I Athanasiadis
EKEfstathios Kenanidis
Efstathios Kenanidis
MPMichael Potoupnis
Michael Potoupnis
ETEleftherios Tsiridis
Eleftherios Tsiridis
Osteosarcoma is the most common primary bone sarcoma. Currently, the main treatment option for high-grade osteosarcomas is neoadjuvant chemotherapy, followed by surgical resection of the lesion and adjuvant chemotherapy. Limb salvage surgery (LSS) and amputation are the main surgical techniques; however, controversy still exists concerning the best surgical method. Our meta-analysis compared the effectiveness of LSS and amputation combined with neoadjuvant chemotherapy in patients with limb osteosarcoma, in terms of 5-year overall survival (OS), 5-year disease-free survival (DFS) and local recurrence rate. Following the established methodology of PRISMA guidelines, a literature search was conducted in PubMed, Cochrane, Google Scholar from 1975 until January 2020. Two independent reviewers evaluated the study quality based on the Newcastle-Ottawa scale. Odds ratio and 95% confidence interval of the OS, DFS and local recurrence rate were calculated. Thirteen studies were finally included with a total of 2884 patients; 1986 patients undergone LSS and 898 amputations. Five-year overall survival was almost 2-fold in patients treated with LSS than those treated with amputation (OR: 1.99; 95% CI: 1.35–2.93; I2 = 74%, p < 0.001). No difference was found in 5-year DFS between LSS patients and amputees (OR: 1.24; 95% CI: 0.55–2.79; I2 = 67%, p = 0.01). The odds of local recurrence was numerically higher in LSS compared to amputation but not statistically significant (OR: 2.29; 95% CI: 0.95–5.53; I2 = 47%, p = 0.05). However, the included studies did not clearly define differences in the stages of patients of the two groups. Our study demonstrated that in patients with limb osteosarcoma treated with neoadjuvant chemotherapy, LSS is associated with a higher 5-year overall survival and the odds of local recurrence may be increased but these results should be interpreted with caution due to high heterogeneity.

1 June 2019 in Journal of Bone Oncology
Verified
Journal Article
Open access
ASAlexandros Stamatopoulos
Alexandros Stamatopoulos
TSTheodosios Stamatopoulos
Theodosios Stamatopoulos
ZGZakareya Gamie
Zakareya Gamie
EKEustathios Kenanidis
Eustathios Kenanidis
RRRicardo Da Conceicao Ribeiro
Ricardo Da Conceicao Ribeiro
ETEleftherios Tsiridis
Eleftherios Tsiridis
Over the past few decades, there has been growing interest in understanding the molecular mechanisms of cancer pathogenesis and progression, as it is still associated with high morbidity and mortality. Current management of large bone sarcomas typically includes the complex therapeutic approach of limb salvage or sacrifice combined with pre- and postoperative multidrug chemotherapy and/or radiotherapy, and is still associated with high recurrence rates. The development of cellular strategies against specific characteristics of tumour cells appears to be promising, as they can target cancer cells selectively. Recently, Mesenchymal Stromal Cells (MSCs) have been the subject of significant research in orthopaedic clinical practice through their use in regenerative medicine. Further research has been directed at the use of MSCs for more personalized bone sarcoma treatments, taking advantage of their wide range of potential biological functions, which can be augmented by using tissue engineering approaches to promote healing of large defects. In this review, we explore the use of MSCs in bone sarcoma treatment, by analyzing MSCs and tumour cell interactions, transduction of MSCs to target sarcoma, and their clinical applications on humans concerning bone regeneration after bone sarcoma extraction.

7 October 2016 in Respiratory Medicine Case Reports
Verified
Journal Article
Open access
ASAlexandros Stamatopoulos
Alexandros Stamatopoulos
DPDavide Patrini
Davide Patrini
Efstratios N KoletsisEfstratios N Koletsis
Efstratios N Koletsis
EBElaine Borg
Elaine Borg
RKReena Khiroya
Reena Khiroya
NPNikolaos Panagiotopoulos
Nikolaos Panagiotopoulos
IgG4-related disease (IgG4-RD) is a fibroinflammatory condition that can affect practically every organ. Although it was first identified in pancreas and salivary glands, major organs like liver, biliary tree, kidney, thyroid glands and lungs are commonly involved, sometimes resulting in organ failure. We describe a case of an 41-year-old man presented with back pain after a rotator cuff injury. A Computed Tomography (CT) revealed incidentally a right lower lobe paravertebral lesion extending across the T5 and T6 vertebral levels and invading into the adjacent pleural surface. The laboratory findings and the CT guided biopsy were inconclusive. Morphological and immunohistochemical findings after a lung biopsy by video-assisted thoracic surgery (VATS) were suggestive to IgG4-related lung disease (IgG4-RLD), which was confirmed with high serum levels of IgG4. This represents the first case of a IgG4-RLD lesion located in the mediastinum and extending to the adjacent pleural surface and vertebrae and should be included in the differential diagnosis of posterior mediastinal masses.

15 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
KBKyriakos Bekas
Kyriakos Bekas
IBIoannis Bampis
Ioannis Bampis
ASAlexandros Stamatopoulos
Alexandros Stamatopoulos
APApostolos-Apollon Papadimitriou
Apostolos-Apollon Papadimitriou
KVKonstantinos Vamvakeros
Konstantinos Vamvakeros
ABAchilleas Boutsiadis
Achilleas Boutsiadis
Background/Objectives: The COVID-19 pandemic limited access to in-person physiotherapy, raising concerns about post-operative rehabilitation outcomes. This study evaluated whether a self-rehabilitation protocol with virtual consultations after a mini-open Latarjet procedure affected short-term clinical outcomes in active military personnel. Materials and Methods: We prospectively enrolled 18 patients (19 shoulders) undergoing mini-open Latarjet between May and October 2020. Patients performed a standardized self-rehabilitation protocol starting on the first post-operative day, with progressive range-of-motion (ROM) exercises added at two weeks. Pain was assessed using the Visual Analog Scale (VAS), ROM was recorded at each follow-up, complications were noted, and patient satisfaction was evaluated at 12 weeks. Results: A total of eighteen patients were prospectively enrolled in the study. At 12 weeks, mean VAS decreased from 1.2 ± 0.6 at week 1 to 0 at week 4 onward. The mean drug consumption was 2.5 ± 0.7 tablets/day only for the first week. Mean assisted forward flexion improved from 155°± 10° at week 1 to 180° in all patients by week 4. External rotation reached 60°± 5°at 4 weeks, 75°± 4° at 8 weeks, and 80°± 3°at 12 weeks, with no deficits compared to the contralateral side. Internal rotation improved to T7 level by week 8 and remained stable at week 12. No complications, recurrent instability, or graft displacements were reported. Patient satisfaction exceeded 9.5/10 in all cases. Conclusions: A self-rehabilitation protocol after mini-open Latarjet surgery yielded excellent short-term outcomes in young military patients, with full ROM recovery, high satisfaction, and no complications. Further validation of these results requires larger, rigorously controlled studies.

7 December 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
KBKyriakos Bekas
Kyriakos Bekas
IBIoannis Bampis
Ioannis Bampis
ASAlexandros Stamatopoulos
Alexandros Stamatopoulos
APApostolos-Apollon Papadimitriou
Apostolos-Apollon Papadimitriou
KVKonstantinos Vamvakeros
Konstantinos Vamvakeros
ABAchilleas Boutsiadis
Achilleas Boutsiadis
Background/Objectives: The COVID-19 pandemic limited access to in-person physiotherapy, raising concerns about post-operative rehabilitation outcomes. This prospective observational study, without a control group, evaluated whether a self-rehabilitation protocol following a mini-open Learjet procedure influenced short-term clinical outcomes in active military personnel. Materials and Methods: We prospectively enrolled 18 patients (19 shoulders) undergoing mini-open Latarjet between May and October 2020. Patients performed a standardized self-rehabilitation protocol starting on the first post-operative day, with progressive range-of-motion (ROM) exercises added at two weeks. Pain was assessed using the Visual Analog Scale (VAS), ROM was recorded at each follow-up, complications were noted, and patient satisfaction was evaluated at 12 weeks. Results: A total of eighteen patients were prospectively enrolled in the study. At 12 weeks, mean VAS decreased from 1.2 ± 0.6 at week 1 to 0 at week 4 onward. The mean drug consumption was 2.5 ± 0.7 tablets/day only for the first week. Mean assisted forward flexion improved from 155° ± 10° at week 1 to 180° in all patients by week 4. External rotation reached 60° ± 5°at 4 weeks, 75° ± 4° at 8 weeks, and 80° ± 3°at 12 weeks, with no deficits compared to the contralateral side. Internal rotation improved to the T7 level by week 8 and remained stable in week 12. No complications, recurrent instability, or graft displacements were reported. Patient satisfaction at 12 weeks was assessed using a 0–10 numeric rating scale, with a mean score of 9.5 ± 0.4. Conclusions: Implementation of a self-rehabilitation protocol after mini-open Latarjet surgery was associated with favorable short-term outcomes in young military patients, including early recovery, high satisfaction, and absence of complications. Further validation of these findings will require larger, rigorously controlled studies.